These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30642228)

  • 21. The frequency and influence of dementia risk factors in prodromal Alzheimer's disease.
    Bos I; Vos SJ; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Engelborghs S; Niemantsverdriet E; De Roeck EE; Tsolaki M; Freund-Levi Y; Johannsen P; Vandenberghe R; Lleó A; Alcolea D; Frisoni GB; Galluzzi S; Nobili F; Morbelli S; Drzezga A; Didic M; van Berckel BN; Salmon E; Bastin C; Dauby S; Santana I; Baldeiras I; de Mendonça A; Silva D; Wallin A; Nordlund A; Coloma PM; Wientzek A; Alexander M; Novak GP; Gordon MF; ; Wallin ÅK; Hampel H; Soininen H; Herukka SK; Scheltens P; Verhey FR; Visser PJ
    Neurobiol Aging; 2017 Aug; 56():33-40. PubMed ID: 28482212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
    J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application guidelines and research progress of biomarkers for Alzheimer's disease].
    Wang XY; Li M; Lu ZM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Mar; 56(3):262-269. PubMed ID: 35381646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When Does Alzheimer's Disease Really Start? The Role of Biomarkers.
    Lloret A; Esteve D; Lloret MA; Cervera-Ferri A; Lopez B; Nepomuceno M; Monllor P
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.
    Robinson JL; Corrada MM; Kovacs GG; Dominique M; Caswell C; Xie SX; Lee VM; Kawas CH; Trojanowski JQ
    Acta Neuropathol; 2018 Sep; 136(3):377-388. PubMed ID: 29916037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia.
    Raszewski G; Chwedorowicz R; Chwedorowicz A; Gustaw Rothenberg K
    Ann Agric Environ Med; 2016; 23(1):193-6. PubMed ID: 27007541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease-related plaques in nondemented subjects.
    Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
    Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
    Hyman BT; Phelps CH; Beach TG; Bigio EH; Cairns NJ; Carrillo MC; Dickson DW; Duyckaerts C; Frosch MP; Masliah E; Mirra SS; Nelson PT; Schneider JA; Thal DR; Thies B; Trojanowski JQ; Vinters HV; Montine TJ
    Alzheimers Dement; 2012 Jan; 8(1):1-13. PubMed ID: 22265587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
    Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
    Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
    Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
    Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of infarcts on dementia in the Baltimore longitudinal study of aging.
    Troncoso JC; Zonderman AB; Resnick SM; Crain B; Pletnikova O; O'Brien RJ
    Ann Neurol; 2008 Aug; 64(2):168-76. PubMed ID: 18496870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis.
    Fiest KM; Roberts JI; Maxwell CJ; Hogan DB; Smith EE; Frolkis A; Cohen A; Kirk A; Pearson D; Pringsheim T; Venegas-Torres A; Jetté N
    Can J Neurol Sci; 2016 Apr; 43 Suppl 1():S51-82. PubMed ID: 27307128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.
    Zammit AR; Hall CB; Katz MJ; Muniz-Terrera G; Ezzati A; Bennett DA; Lipton RB
    J Alzheimers Dis; 2018; 66(1):347-357. PubMed ID: 30282367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The National Institute on Aging Centers on the demography and economics of aging and Alzheimer's disease and Alzheimer's related dementias: History, impact, and future challenges.
    Sonnega A; Mather M; Scommegna P
    J Am Geriatr Soc; 2024 May; 72(5):1598-1601. PubMed ID: 38445825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.